Safety, Monitoring, and Eligibility Considerations Orderly Meds Review includes built-in safety screens for contraindications: personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, acute pancreatitis, severe renal impairment, and active diabetic retinopathy progression
1:05:38: Heart disease is still the number one killer in both men and women
Muscle loss: Some reports suggest that rapid weight loss from GLP-1s may lead to a decrease in muscle mass
| Verification Step | Where to Check | Pass Criteria | |---|---|---| | Prescriber license | FSMB DocInfo | Active, unrestricted, licensed in patient's state | | Pharmacy NABP status | NABP Drug Outlet Database | Current accreditation, no disciplinary action | | LegitScript certification | LegitScript.com lookup | Certified status, not "rogue" or "not recommended" | | Compounded drug legal basis | Ask platform directly | Written explanation citing FDA 503A/503B registration | | BBB record | BBB.org | Review complaint patterns, not just star rating | | Subscription cancellation terms | Platform Terms of Service | Clear cancellation process, no auto-renewal traps | | Clinical eligibility criteria | Platform intake form | BMI 30 or BMI 27 plus documented comorbidity | How GLP-1 Outcomes Should Be Measured in a Telehealth Setting Even if Willow collected outcomes data internally, the metrics matter
Severe anxiety, panic attacks, or depressive symptoms accompanying insomnia require prompt evaluation
